{
  "catalogId": "78641f5a-3d5d-49e4-855f-aecd60cf9472",
  "name": "JULUCA",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "161 69 35445 00",
  "treatmentDescriptions": "Juluca is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically-suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "RILPIVIRINE AS HYDROCHLORIDE, DOLUTEGRAVIR AS SODIUM",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "J05AR21",
      "name": "DOLUTEGRAVIR AND RILPIVIRINE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "JULUCA 30 tab",
      "manufacturer": {
        "name": "ג.ס.ק",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8302",
        "yarpa": "26818",
        "pharmasoft": "10395"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 2533.173667,
        "retailMargin": 10.0,
        "maxRetailPrice": 2786.491034,
        "maxPriceWithVAT": 3288.059274
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.616127"
  }
}